跳至主要内容
临床试验/CTRI/2022/07/044007
CTRI/2022/07/044007暂停3 期

A double blind randomized controlled trial to compare the serological response to 1.0 ml versus 2.0 ml intramuscular four doses schedule of hepatitis B vaccine in pre-dialysis chronic kidney disease (CKD) patients with eGFR below 60 ml/min

Indian Council of Medical Research ICMR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
暂停
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • (i) Adults of between 19-45 years of age
  • (ii) Who are unlikely to need MHD in next one year
  • (iii) Not had ever received hepatitis B vaccination, as suggested by history
  • (iv) HBsAg negative
  • (v) Body mass index (BMI) between 18.5-25 Kg/m2

排除标准

  • (i) Hepatitis C virus or HIV coinfection
  • (ii) Post-renal or other organ transplant recipients
  • (iii) On immunosuppressive medication, regardless of indication
  • (iv) Any chronic immunodeficiency condition
  • (v) Presence of malignancy, regardless of its nature and stage of disease
  • (vi) Presence of autoimmune condition
  • (vii) active alcohol intake or current smoker
  • (viii) Smoking or alcohol intake till recent past ( <6months)
  • (ix) Pregnant and lactating women

研究者

发起方
Indian Council of Medical Research ICMR

相似试验